TherapeuticsMD, Inc.
TXMD
$1.10
$0.01991.84%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.07M | 5.75M | 5.06M | 5.05M | 5.23M |
| Total Receivables | 3.74M | 3.00M | 3.56M | 3.32M | 2.91M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 168.00K | 231.00K | 70.00K | 161.00K | 168.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.48M | 3.54M | 3.57M | 3.62M | 3.52M |
| Total Current Assets | 13.46M | 12.51M | 12.26M | 12.15M | 11.82M |
|
|
|||||
| Total Current Assets | 13.46M | 12.51M | 12.26M | 12.15M | 11.82M |
| Net Property, Plant & Equipment | 5.73M | 5.95M | 6.10M | 6.30M | 6.50M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 4.04M | 4.14M | 4.32M | 4.43M | 4.52M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 15.27M | 15.64M | 16.14M | 16.67M | 17.28M |
| Total Assets | 38.50M | 38.24M | 38.82M | 39.55M | 40.13M |
|
|
|||||
| Total Accounts Payable | 350.00K | 176.00K | 258.00K | 234.00K | 143.00K |
| Total Accrued Expenses | 704.00K | 769.00K | 494.00K | 1.20M | 1.09M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 886.00K | 1.01M | 1.63M | 1.62M | 1.59M |
| Total Finance Division Other Current Liabilities | 2.72M | 2.79M | 2.78M | 2.92M | 3.00M |
| Total Other Current Liabilities | 2.72M | 2.79M | 2.78M | 2.92M | 3.00M |
| Total Current Liabilities | 4.66M | 4.74M | 5.17M | 5.98M | 5.82M |
|
|
|||||
| Total Current Liabilities | 4.66M | 4.74M | 5.17M | 5.98M | 5.82M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.72M | 5.96M | 5.54M | 5.78M | 6.00M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 832.00K | 795.00K | 744.00K | 705.00K | 637.00K |
| Total Liabilities | 11.21M | 11.50M | 11.45M | 12.46M | 12.46M |
|
|
|||||
| Common Stock & APIC | 979.22M | 979.22M | 979.19M | 979.17M | 979.14M |
| Retained Earnings | -951.92M | -952.48M | -951.82M | -952.07M | -951.47M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 27.29M | 26.74M | 27.37M | 27.09M | 27.67M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 27.29M | 26.74M | 27.37M | 27.09M | 27.67M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 27.29M | 26.74M | 27.37M | 27.09M | 27.67M |
|
|
|||||